Pharmacokinetic Analysis of Midazolam and Fentanyl in Pediatric Patients With Long-term Analgosedation
NCT ID: NCT02302391
Last Updated: 2021-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2014-10-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support
NCT03593408
Effects on Recovery of Children of Intravenous Formulation of Fentanyl Citrate and Midazolam Orally for Premedication
NCT05500599
Efficacy of iv Fentanyl Citrate Administered Oral as a Pediatric Premedication
NCT04991298
Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children
NCT01091818
Fentanyl Versus Midazolam as an Adjunct to Intrathecal Bupivacaine In Children
NCT03592537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Three Age Groups (infants, children and adolescents) will be evaluated considering the physiologic properties during pediatric development.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midazolam/fentanyl: PK analysis
Pediatric intensive care patients under analgosedation with midazolam and fentanyl.
PK analysis
Quantification of Serum Levels and subsequent pharmacokinetic (PK) modelling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PK analysis
Quantification of Serum Levels and subsequent pharmacokinetic (PK) modelling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mechanical ventilation more than 3 days
* analgosedation with midazolam and fentanyl
Exclusion Criteria
28 Days
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr.med. Dominique Singer
Head of Section Neonatology and Pediatric Intensive Care, University Medical Center Hamburg-Eppendorf
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Singer, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Hamburg-Eppendorf, Department of Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Hamburg-Eppendorf
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PV4546
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.